Galimedix names Alzheimer's Scientific Advisory Board
Galimedix Therapeutics Inc said it has established a dedicated Alzheimer's Disease Scientific Advisory Board to provide scientific and clinical guidance as the company advances its Alzheimer's drug candidate GAL-101 through clinical development.